Aardvark Therapeutics, Inc. (AARD) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Aardvark Therapeutics, Inc. (AARD) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Aardvark Therapeutics, Inc.

· AARD

Dashboard

Financials

Ratios

Valuation

Statistics

117.084 M

-1.50%

General

Market Cap: $117.08M
Enterprise Value: $42.16M
Shares Outstanding: 21,880,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -85.80%
ROE: -71.54%
ROIC: -97.99%
Current Ratio: 12.63
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.02
P/S: —
P/FCF: —
P/B: 1.54
EV/EBITDA: -0.60

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $73.96M
Operating Income: -$73.96M
Net Profit: -$69.89M

Balance Sheet

Cash and Equivalents: $73.85M
Working Capital: $74.27M
Total Assets: $81.46M
Net Debt: -$73.17M
Total Liabilities: $6.66M
Total Equity: $74.8M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$69.41M
Cash Flow from Investing: $116.55M
Cash Flow from Financing: $711K
Free Cash Flow: -$69.41M
Capital Expenditures: $4K